Claims of efficacy

China ／ NMPA

Advertisements for medical services, drugs and medical devices must not contain assertions or guarantees of efficacy or safety, nor state cure rates or effectiveness rates, and the content of a drug advertisement must not be inconsistent with the package insert approved by the drug regulator.

医療・医薬品・医療機器の広告は、効能や安全性についての断定または保証、および治癒率や有効率の記載を含んではならず、医薬品広告の内容は国務院薬品監督管理部門が承認した添付文書と矛盾してはならない。

statuteAdvertising Law of the People's Republic of China (as amended 2021), articles 16(1), 16(2) and article 16 paragraph 2checked 2026-09-23

Note
PDF of the NPC Standing Committee Gazette text hosted on the SAMR legal database. The implementing measures add that where a drug advertisement covers the product name, indications or functions, or pharmacological action, it must not go beyond the scope of the package insert (SAMR Order No. 21, article 5).

The same topic elsewhere

Japan ── Expressions of the efficacy, effect or performance of a product requiring appr…United States ── A prescription drug advertisement is false, lacking in fair balance, or otherw…Canada ── No person may label, package, treat, process, sell or advertise a drug in a ma…European Union ── All parts of the advertising of a medicinal product must comply with the parti…United Kingdom ── An advertisement for a medicinal product with a UK marketing authorisation mus…Australia ── An advertisement about therapeutic goods must be accurate, balanced and not mi…Korea ── False or exaggerated advertising about the name, manufacturing method, efficac…Switzerland ── All statements in professional advertising must be consistent with the medicin…